Fresenius Medical Care AG banner

Fresenius Medical Care AG
DUS:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
DUS:FME
Watchlist
Price: 40.55 EUR -1.43% Market Closed
Market Cap: €23.8B

Wall St Price Targets

FME Price Targets Summary
Fresenius Medical Care AG

Wall Street analysts forecast FME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FME is 44.01 EUR with a low forecast of 22.26 EUR and a high forecast of 64.66 EUR.

Lowest Forecast
Price Target
22.26 EUR
45% Downside
Average Forecast
Price Target
44.01 EUR
9% Upside
Highest Forecast
Price Target
64.66 EUR
59% Upside
Fresenius Medical Care AG Competitors:
Price Targets
VNET
Vianet Group PLC
225% Upside
YUMC
Yum China Holdings Inc
50% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

Gross Profit
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

0% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FME's stock price target?
Price Target
44.01 EUR

According to Wall Street analysts, the average 1-year price target for FME is 44.01 EUR with a low forecast of 22.26 EUR and a high forecast of 64.66 EUR.

What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

What is the Gross Profit forecast for Fresenius Medical Care AG?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for Fresenius Medical Care AG?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett